Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-30 @ 6:25 AM
Study NCT ID:
NCT00564512
Status:
COMPLETED
Last Update Posted:
2013-07-25
First Post:
2007-11-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fludarabine, Cyclophosphamide, and Rituximab or Alemtuzumab in Treating CLL2007 CLL 2007 FMP
Sponsor:
French Innovative Leukemia Organisation
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000577580
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None